ProfileGDS4814 / ILMN_1809866
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 91% 90% 92% 92% 91% 91% 91% 92% 91% 90% 92% 92% 93% 91% 92% 92% 92% 92% 92% 93% 92% 92% 91% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)496.27291
GSM780708Untreated after 4 days (C2_1)427.25790
GSM780709Untreated after 4 days (C3_1)542.30792
GSM780719Untreated after 4 days (C1_2)532.64692
GSM780720Untreated after 4 days (C2_2)445.65891
GSM780721Untreated after 4 days (C3_2)489.72791
GSM780710Trastuzumab treated after 4 days (T1_1)450.29891
GSM780711Trastuzumab treated after 4 days (T2_1)562.58892
GSM780712Trastuzumab treated after 4 days (T3_1)480.68991
GSM780722Trastuzumab treated after 4 days (T1_2)393.67790
GSM780723Trastuzumab treated after 4 days (T2_2)539.11792
GSM780724Trastuzumab treated after 4 days (T3_2)514.56592
GSM780713Pertuzumab treated after 4 days (P1_1)603.36793
GSM780714Pertuzumab treated after 4 days (P2_1)484.27291
GSM780715Pertuzumab treated after 4 days (P3_1)552.43292
GSM780725Pertuzumab treated after 4 days (P1_2)564.27692
GSM780726Pertuzumab treated after 4 days (P2_2)525.6392
GSM780727Pertuzumab treated after 4 days (P3_2)554.33792
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)507.56892
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)603.0193
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)546.38192
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)540.10892
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)441.11591